ATP binding cassette subfamily G member 2 (ABCG2) Genotyping
ATB binding cassette subfamily G member 2 (ABCG2) is a transport protein encoded by the ABCG2 gene which is located at 4q22. It is responsible for the synthesis of ABCG2 protein which is a transmembrane protein that functions to transport molecules across the cell membrane. It is believed to be an important defense mechanism in purging xenobiotic and toxins out of cells. It also has an important role in excreting urate formed during purine metabolism. ABCG2 is present in the kidney and functions to excrete urates into the urine. It is also present in the intestine where it functions to excrete urates into stool.
Mutations in the ABCG2 gene may result in either impaired function, decreased expression or complete absence of ABCG2 protein. One mutation, Gln141Lys is responsible for diminished function of ABCG2 while another mutation, Gln126Ter results in complete absence of ABCG2. Individuals with mutations or pathogenic variants are susceptible to hyperuricemia and may develop gout at an early age. Overexpression of ABCG2 in breast cancer cells, causes rapid efflux of chemotherapeutic drugs such as anthracycline and chemotherapy resistance.
The other role ABCG2 is pharmacogenetics of statins and cancer drugs. Overall, the ABCG2 421C>A SNP has an impact on the plasma concentration ofrosuvastatin, fluvastatin, and possibly atorvastatin. The effect of ABCG2 421C>A SNP is strongest on rosuvastatin disposition, with subjects with the ABCG2 421 AA genotype having about 2-fold higher systemic exposure compared to subjects with the ABCG2 421 CC genotype. The elimination half-life of rosuvastatin is not affected by ABCG2 421 C>A variant, suggesting that the increase in the statin plasma concentration is probably due to an enhanced absorption of the drug after oral administration (as a consequence of decreased intestinal efflux by ABCG2). Studies investigating the effects of ABCG2 421C>A variant on fluvastatin pharmacokinetics showed that carriers of the A allele have a higher risk of developing adverse events.
- Useful in investigating hyperuricemia and gout
- Helpful in screening neonates and family members with a familial history of gout
- Pharmacogenetics of statins (rosuvastatin, fluvastatin, and possibly atorvastatin) and anticancer drugs
Normal ABCG2 function: 421C>A C/C
- Whole blood, Lavender-top (EDTA) or yellow-top (ACD) tube, buccal swab.
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: unstable
- Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):275-81 [PMID: 24940679]
- Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):266-74. [PMID: 24940678]
- Expert Opin Drug Metab Toxicol. 2008 Jan;4(1):1-15. [PMID: 18370855]
- J Clin Oncol. 2002 Jul 1;20(13):2943-50. [PMID: 12089223]
- Breast Dis. 2020;39(3-4):137-142 [PMID: 32894234]
- Int J Biochem Mol Biol. 2012;3(1):1-27 [PMID: 22509477]